| Literature DB >> 27725379 |
Toshiaki Sasaki1, Masumi Asakura, Chigusa Ishioka, Tatsuya Kasai, Taku Katagiri, Shoji Fukushima.
Abstract
OBJECTIVES: IARC has classified one type of multi-walled carbon nanotubes (MWCNTs), MWNT-7, as possibly carcinogenic to humans (Group 2B); however, other types of MWCNT were categorized as not classifiable as to their carcinogenicity to humans (Group 3). In vitro chromosomal aberration assays of MWNT-7 showed polyploid formation but not structural abnormalities. This study investigated the influence of the shape and size of MWCNT on in vitro induction of chromosomal aberrations.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27725379 PMCID: PMC5373912 DOI: 10.1539/joh.16-0099-OA
Source DB: PubMed Journal: J Occup Health ISSN: 1341-9145 Impact factor: 2.708
Fig. 1.An SEM image showing isolated fibers or tangles of MWCNTs in the medium. The white bar indicates 5 µm, and the black bar indicates 2 µm. Two straight fibrous types (A: CTa and B: CTb), two curved fibrous types (C: CTc and D: CTd), and three tangled types (E: CTe, F: CTf, and G: CTg) are shown. The concentrations of the MWCNT suspensions were CTa and CTb: 20 µg/ml; CTc, CTd, CTe, and CTg: 62 µg/ml; CTf: 40 µg/ml.
Summary of characteristics of MWCNTs and polyploidy induction
| CTae) | CTb | CTc | CTd | CTe | CTf | CTg | |
|---|---|---|---|---|---|---|---|
|
a) Fibrous types (CTa, CTb, CTc, CTd) showed fiber length, tangled types (CTe, CTf, CTg) showed long axis. | |||||||
| Shape | fiber (straight) | fiber (straight) | fiber (curve) | fiber (curve) | tangle (cluster) | tangle (shattered CTe) | tangle (spherical) |
| Length (µm)a) | 5.7 ± 3.6f) | 3.6 ± 1.7 | 4.0 ± 3.8 | 4.2 ± 3.9 | 8.3 ± 5.2 | 3.3 ± 3.3 | 3.3 ± 3.1 |
| Width (nm)b) | 91 ± 21f) | 144 ± 25 | 65 ± 12 | 63 ± 12 | 2300 ± 2400 | 2300 ± 2400 | 2300 ± 2200 |
| Structural abberrationc) | – | – | – | – | – | – | – |
| Polyploidy inductiond) | + | + | + | + | + | – | – |
| (1.2 µg/m | (1.2 µg/m | (21 µg/m | (62 µg/m | (100 µg/m | |||
Structural aberration and polyploidy induction of MWCNTs with CHL/IU cells
| Treatment | Concentration (μg/m | Percentages (%) of structural aberration cells | Percentages (%) of polyploidy cells | Relative cell growth (%) | ||
|---|---|---|---|---|---|---|
| Cell No. | CAa) | Cell No. | Polyploidy | |||
|
a)CA: Structural chromosomal aberrations. | ||||||
| CTa | 0 | 200 | 0 | 203 | 1.5 | 100 |
| 0.31 | 200 | 0 | 207 | 3.4 | 92 | |
| 1.2 | 200 | 0 | 216 | 7.4** | 91 | |
| 4.9 | 200 | 0 | 242 | 17.4** | 89 | |
| 20 | 200 | 0 | 285 | 29.8** | 82 | |
| 78 | 200 | 1.0 | 306 | 34.6** | 64 | |
| MMCb) | 0.032 | 200 | 76.0** | 201 | 0.5 | – |
| CTb | 0 | 200 | 0.5 | 201 | 0.5 | 100 |
| 0.31 | 200 | 0 | 203 | 1.5 | 88 | |
| 1.2 | 200 | 0 | 211 | 5.2* | 92 | |
| 4.9 | 200 | 0 | 223 | 10.3** | 94 | |
| 20 | 200 | 0.5 | 262 | 23.7** | 67 | |
| 78 | 200 | 0 | 300 | 33.3** | 43 | |
| MMCb) | 0.032 | 200 | 42.0** | 200 | 0 | – |
| CTc | 0 | 200 | 0 | 202 | 1.0 | 100 |
| 6.9 | 200 | 0 | 207 | 3.4 | 98 | |
| 21 | 200 | 0 | 213 | 6.1** | 96 | |
| 62 | 200 | 0.5 | 221 | 9.5** | 94 | |
| 190 | 200 | 0 | 226 | 11.5** | 91 | |
| 560 | 200 | 0.5 | 235 | 14.9** | 90 | |
| MMCb) | 0.032 | 200 | 51.0** | 201 | 0.5 | – |
| CTd | 0 | 200 | 0 | 202 | 1.0 | 100 |
| 6.9 | 200 | 0 | 204 | 2.0 | 101 | |
| 21 | 200 | 0 | 211 | 5.2 | 99 | |
| 62 | 200 | 0 | 214 | 6.5* | 97 | |
| 190 | 200 | 0 | 222 | 9.9** | 94 | |
| 560 | 200 | 0 | 232 | 13.8** | 90 | |
| 1700 | 200 | 0 | 240 | 16.7** | 81 | |
| MMCb) | 0.032 | 200 | 47.5** | 200 | 0 | – |
| CTe | 0 | 200 | 0 | 201 | 0.5 | 100 |
| 25 | 200 | 0 | 202 | 1.0 | 97 | |
| 50 | 200 | 0 | 208 | 3.8 | 97 | |
| 100 | 200 | 0 | 212 | 5.7** | 96 | |
| 200 | 200 | 0 | 219 | 8.7** | 93 | |
| 300 | 200 | 0 | 228 | 12.3** | 91 | |
| MMCb) | 0.032 | 200 | 66.0** | 200 | 0 | – |
| CTf | 0 | 200 | 0.5 | 203 | 1.5 | 100 |
| 310 | 200 | 0 | 205 | 2.4 | 100 | |
| 630 | 200 | 0.5 | 206 | 2.9 | 99 | |
| 1300 | 200 | 0.5 | 205 | 2.4 | 91 | |
| 2500 | 200 | 0 | 201 | 0.5 | 80 | |
| 5000 | 200 | 0 | 201 | 0.5 | 38 | |
| MMCb) | 0.032 | 200 | 52.0** | 200 | 0 | – |
| CTg | 0 | 200 | 0.5 | 203 | 1.5 | 100 |
| 310 | 200 | 1.0 | 204 | 2.0 | 100 | |
| 630 | 200 | 0 | 203 | 1.5 | 96 | |
| 1300 | 200 | 0 | 205 | 2.4 | 74 | |
| 2500 | 200 | 2.5 | 207 | 3.4 | 64 | |
| 5000 | TOX | TOX | 3 | |||
| MMCb) | 0.032 | 200 | 76.5** | 200 | 0 | – |
Fig. 2.Four types of MWCNTs localized in the cytoplasm of CHL/IU cells can be observed in cells with partially removed surface membranes areas. The cells were exposed to the four MWCNTs at 2.5 (CTa) and 100 (CTd, CTe, and CTf) µg/ml for 48 h. A: An SEM image showing isolated long CTa fibers completely internalized into a CHL/IU cell. B: An SEM image showing entangled CTd fibers, similar to a bird’s nest, internalized into a cell. C: An SEM image showing a large CTe cluster completely internalized into a cell. D: An SEM image showing small CTf aggregates scattered in the cytoplasm of a cell. The white bar indicates 5 µm. Arrows indicate internalized MWCNTs.
Fig. 3.A model for cellular uptake of MWCNTs with different shapes. A: Straight fibrous MWCNT; B: Curved fibrous MWCNT; C: Tangled MWCNT, a large cluster of associated spherical aggregates; D: Tangled MWCNT, small individual aggregates. The lengths of deformable curved fibrous MWCNT may be smaller after endocytosis than before endocytosis (B). The shape and size of non-deformable straight fibrous MWCNT (A) and tangled MWCNT (C, D) are not altered by endocytosis (see Fig. 2). Small tangled MWCNTs (D) are endocytosed into roughly spherical rather than elongated endosomes that do not effectively interfere with cytokinesis.